Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong

Trial Identifier:	D5160R00019
Sponsor:	AstraZeneca
NCTID::	NCT03519958
Start Date:	September 2018
Primary Completion Date:	November 2020
Study Completion Date:	November 2020
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.